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Objective:Homograft aortic valve replacement is associated with excellent clinical and hemodynamic outcomes.
Valves are implanted predominantly by using 2 techniques: the freehand subcoronary technique or as an aortic
root replacement. Our aim was to identify any difference in survival, durability, and clinical performance.
Methods: Demographic, operative, and clinical data were obtained retrospectively through case-note review. All
operations were performed by a single surgeon. Propensity score–adjusted analysis was used by developing
a nonparsimonious logistic regression model for implantation with subcoronary versus root replacement. Actu-
arial survival and freedom from valve-related events were compared with Kaplan–Meier curves and multivariable
proportional hazard Cox regression.
Results: Between January 1, 1991, and January 1, 2001, 215 patients underwent aortic valve replacement with
a homograft. The subcoronary technique was used in 131 (61%) patients. Eighty-four (39%) patients underwent
free-standing aortic root replacement. After propensity risk adjustment, the subcoronary implantation technique
was associated with a decreased risk of 30-day death (adjusted odds ratio, 0.18; 95% confidence interval,
0.06–0.34; P ¼ .03). Technique of insertion was not an independent predictor of overall mortality during
follow-up after adjustment (propensity adjusted hazard ratio, 0.35; 95% confidence interval, 0.09–1.41;
P ¼ .18). There were no significant differences in 1- and 5-year actuarial survival, freedom from structural valve
disease, endocarditis, or reoperation.
Conclusions: Both the subcoronary and root replacement techniques for homograft aortic valve replacement are
associated with excellent midterm survival and clinical performance. Root replacement was associated with an
increased risk of perioperative death after adjustment for covariates by using propensity analysis.Since its introduction, the aortic valve homograft has been
used successfully for almost 50 years.1-3 Two predominant
methods are used for homograft valve implantation. The
initial experience was with subcoronary implantation
within the patient’s native aortic root.1 More recently,
there has been an increased tendency towards using the
homograft for total root replacement (RR).4 Several com-
parisons of clinical performance and durability have been
undertaken over the past 2 decades.5-14 The overwhelming
feature of these studies is that significant heterogeneity has
often existed between the 2 groups. Our aim was to use
propensity scoring to minimize bias, thereby allowing
for a more accurate comparison of the 2 implantation tech-
niques in an attempt to ascertain their true effect on
clinical outcome after homograft aortic valve replacement
(AVR).
MATERIALS AND METHODS
This is a retrospective review of a consecutive series of patients who
underwent AVR with a homograft from 1991 to 2001. Patients were not
excluded from analysis if they had additional concomitant cardiac proce-
dures.
Homograft Preservation Technique
An established homograft cryopreservation protocol has been in place at
our institution for more than 15 years. After sterile procurement, homografts
are placed in nutrient antibiotic solution (Gaya 5) and stored in an incubator
at 37C for 24 hours before refrigeration at 4C. A cryoprotectant (dimethyl
sulfoxide) is added before the valve is placed in a heat-sealed double-sterile
barrier comprised of a sterile nylon pouch and a sterile trilaminate alumin-
ium sachet. The sachet is placed in a controlled-rate freezer, which main-
tains a constant freezing rate of 1C/min. At 60C, the sachet is
transferred to an ultralow freezer and is stored at130C for up to 5 years.
For the purpose of microbiologic screening, 2 sets of tissue samples are re-
moved from the valve at the time of dissection and subjected to identical
treatment and conditions as the homograft. After 24 hours of incubation,
the first set of tissue samples is cultured for bacterial and fungal contami-
nants, and the second set is cultured when the valve is wrapped and packed.
Surgical Technique
Operations were performed by a single surgeon (J.P.). Although the
choice of implant technique was tailored to the individual, homografts
were used more frequently for endocarditis, aortic root disease, and aortic
valve reoperation. All procedures were performed during cardiopulmonary
bypass with cooling to 28C, and myocardial protection was undertaken
with antegrade and retrograde cold blood cardioplegia. With the
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AVR ¼ aortic valve replacement
CI ¼ confidence interval
IQR ¼ interquartile range
RR ¼ root replacement
subcoronary technique, all of the valve sinuses were excised. The valve was
then implanted with separate inflow and outflow suture lines, with the latter
anchoring the commissures and the scalloped edge of the valve to the aortic
wall. For the free-standing RR technique, the allograft was anastomosed en
bloc to the aortic annulus proximally and the ascending aorta distally. The
coronary ostia were then reimplanted as buttons within the allograft.
Data Acquisition
Demographic, clinical, and operative data were obtained from individual
patient hospital records. Our follow-up protocol included annual echocar-
diograms to assess cardiac and homograft valve function. Ethical approval
for the use of patient data was obtained from our institutional review board.
Serial echocardiographic reports were scrutinized for evidence of structural
valve deterioration or nonstructural dysfunction. Mortality was determined
by using the National Health Service Strategic Tracing System, and survi-
vors were contacted by telephone for interview. Operational definitions
were according to joint guidelines of the Society of Thoracic Surgeons
and the American Association for Thoracic Surgery.15
Echocardiographic Details
Patients in our series had yearly echocardiographic follow-up at our in-
stitution. Transthoracic echocardiography was performed with the Sonos
5000 (Hewlett–Packard, Palo Alto, Calif). Two-dimensional images were
obtained by using standard apical, 5-chamber, parasternal short- and long-
axis views. Continuous-wave Doppler scanning was used to determine
the presence and severity of any regurgitation.
Definition of Study End Point and Follow-up
The main end points of interest were 30-day mortality and survival at
follow-up. Secondary end points were valve-related events at follow-up,
such as structural valve degeneration, need for reoperation, and endocardi-
tis. Clinical follow-up data were collected at each clinic visit. Surviving
patients remained under this annual follow-up protocol. Survival and free-
dom from events commenced at the time of operation and ended at the
time of death/event or at last follow-up (censoring).
Statistical Methods
Continuous variables were presented as means  standard deviations or
medians with interquartile ranges (IQRs) for normally and nonnormally dis-
tributed measures, respectively. Categorical variables were shown as per-
centages. Comparisons for continuous variables were performed with
Student’s t or Mann–Whitney U tests, and those for binary variables were
performed with c2 or Fischer’s exact tests, where appropriate.
For binary outcomes, such as 30-day mortality and identification of pre-
dictors, logistic regression was used. Actuarial outcomes were compared
with Kaplan–Meier curves and multivariable Cox proportional hazards
regression. A log-rank test was used to determine whether significant differ-
ences existed between curves. The proportional hazard assumption was
tested for each covariate by using 2 methods: (1) correlating the correspond-
ing scaled Schoenfeld residuals with the rank of time and (2) using the pro-
cedure ‘‘stphtest’’ in Stata (StataCorp, College Station, Tex). The linearity
assumption for each binary covariate was assessed graphically with Martin-
gale residuals. Especially for the propensity score, which was used as the
The Journal of Thoracic and Clinear term (continuous) in Cox regression, we assessed linearity in the fol-
lowing way: first we categorized the propensity variable into 5 dichotomous
variables of equal units, then we inserted each of these in the multivariable
analysis to calculate their coefficients, and finally the coefficients were
graphed against the midpoint of each propensity score variable. All statisti-
cal tests were 2-sided. In all cases corrections were not made for multiple
comparisons. Statistical analysis was performed with SPSS 14.0 (SPSS,
Inc, Chicago, Ill) and Stata 9.0 (Stata Corp, College Station, Tex) software.
The statistical analysis addressed confounding factors (patient selection)
by use of a propensity score and heterogeneity (risk factors) by means of
multivariate risk factor analysis.16,17
The following models were used in our analysis: (1) unadjusted model,
(2) model adjusted for propensity score, and (3) model adjusted for
covariates.
Propensity score model. A propensity score for each patient was
calculated to determine the probability of allocation to either of the 2 groups
and compared (subcoronary ¼ 1 vs RR ¼ 0) by using a nonparsimonious
logistic regression model. The discrimination of the propensity model
was assessed with calculation of the c-statistic. All the variables listed in
Table 1 were included in this model, along with clinically valid interactions.
The selection of variables included in the propensity model was based first
on clinical grounds (taking into account that the independent variable is
a preoperative factor that might be related to surgical technique selection),
second on the percentage of missing data for each candidate variable (only
variables with completeness of data were included), and finally on the value
of the c-statistic to assess the model. The score was subsequently incorpo-
rated into the proportional-hazards models as a covariate. We used the pro-
pensity score for adjustment and not for matching to avoid reduction
in study size. The propensity score analysis was performed as previously
recommended.18,19
Covariates model. A multivariable regression analysis was per-
formed to elucidate associated causative factors to the outcomes of interest.
Initially, univariate regression analysis was used to determine all significant
confounding variables (covariates). Those associated confounding variables
were subsequently included in the multivariable regression model. Only sta-
tistically or clinically significant (P  .1) causative factors from the univar-
iate analysis were adjusted for (included) in the multivariable model. Model
fit was evaluated by using the Hosmer and Lemeshow goodness-of-fit sta-
tistic. All statistical analysis was performed with SPSS 14.0 (SPSS, Inc)
software.
RESULTS
Between January 1, 1991, and January 1, 2001, 215 pa-
tients underwent AVR with a homograft. The subcoronary
technique was used in 131 (61%) patients, and 84 (39%) pa-
tients underwent RR. Patient characteristics according to im-
plant method are demonstrated in Table 2. Subcoronary
implantation was used more commonly for degenerative
calcific aortic stenosis (P< .001). Alternately, RR was the
preferred technique when aortic regurgitation was the
predominant valve lesion or in patients with ascending aortic
aneurysmal disease (P< .001). The RR technique was also
used more frequently for endocarditis (P ¼ .003) and redo
aortic valve operations (P< .001), considerably increasing
the risk profile of this group. Concomitant coronary artery
bypass grafting was more commonly performed in patients
who underwent subcoronary allograft implantation.
Thirty-day mortality was significantly greater among pa-
tients who underwent RR (14.2% vs 2.2%, P < .001).
The causes of 30-day mortality are presented in Table 3.
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tion technique was associated with a decreased risk of
30-day death (adjusted odds ratio, 0.18; 95% confidence in-
terval [CI], 0.06–0.34; P¼ .03). The median follow-up time
was 3.9 years (IQR, 1.6–5.7). There were 25 deaths: 10 in
the subcoronary group and 15 in the RR group. There
were no deaths beyond 1 year in the RR group. The Ka-
plan–Meier 1- and 5-year mortality risks were 88.4%  4%
and 88.4%  4% for the RR group and 97%  1.7% and
93%  3% for the subcoronary group (Figure 1). Kaplan–
Meier analysis did not reveal a significant difference in sur-
vival between the 2 groups (log-rank c2 ¼ 1.87, P ¼ .176).
Subcoronary implantation was not associated with a signifi-
cantly lower risk of late mortality (unadjusted hazard ratio,
0.47; 95% CI, 0.15–1.4; P ¼ .18). After propensity risk
adjustment, there remained no association between implant
technique and an increased risk of late mortality across
follow-up (propensity-adjusted hazard ratio, 0.35; 95% CI,
0.09–1.41; P ¼ .18). The proportionality and linearity
assumptions were not found to be violated. The only
independent predictor of late mortality was a redo operation
(hazard ratio, 3.6; 95% CI, 1.1–12.4; P¼ .04). Left ventricu-
lar impairment demonstrated a strong trend toward being an
independent predictor of late mortality (hazard ratio, 3.8;
95% CI, 0.96–15.5; P ¼ .06).









Age>70 y, n (%) 41 (31) 25 (30) .81
Male sex, n (%) 93 (71) 66 (79) .21
Risk factors
Hypercholesterolemia, n (%) 13 (10) 9 (11) .85
Diabetes, n (%) 10 (8) 3 (4) .26
Hypertension, n (%) 31 (24) 19 (23) .86
Creatinine>150 mmol/L, n (%) 31 (24) 17 (20) .56
Other clinical data
LV impairment, n (%) 27 (21) 19 (23) .72
Pre-NYHA III/IV, n (%) 78 (60) 50 (60) .99
Pre–sinus rhythm, n (%) 32 (24) 26 (31) .29
ACE inhibitor, n (%) 31 (24) 30 (54) .06
Prosthesis size>25 mm, n (%) 6 (4.6) 3 (4) .719
Concomitant CABG, n (%) 34 (26) 9 (11) .006
Cause
Degenerative, n (%) 96 (73) 26 (31) <.001
Rheumatic, n (%) 14 (11) 3 (4) .07
Endocarditis, n (%) 7 (5) 15 (18) .003
Annular dilatation, n (%) 0 (0) 21 (25) <.001
Redo, n (%) 14 (11) 18 (21) .03
Congenital, n (%) 0 (0) 1 (0) .39
Operative indication
Aortic stenosis, n (%) 88 (67) 26 (31) <.001
Aortic regurgitation, n (%) 24 (18) 45 (54) <.001
Mixed valve disease, n (%) 18 (13) 13 (16) .72
Redo operation, n (%) 16 (12) 30 (36) <.001
LV, Left ventricular; NYHA, New York Heart Association; ACE, angiotensin-convert-
ing enzyme; CABG, coronary artery bypass grafting.





Low cardiac output syndrome 6
Root replacement
Unable to wean from CPB 0
Low cardiac output syndrome 0
Systolic cardiac arrest 0
Low cardiac output syndrome 0
Low cardiac output syndrome 1











CVA, Cerebrovascular accident; CPB, cardiopulmonary bypass.
TABLE 3. Predictors of selection for the root replacement or
subcoronary technique: Results of nonparsimonious logistic
regression modeling used to develop the propensity score
Predictor OR (95% CI) P value
Degenerative cause 5.82 (2.1–16.81) .001
Rheumatic cause 11.21 (2.5–50.15) .002
Preoperative sinus rhythm 0.367 (0.14–1.01) .05
Age 1.2 (0.54–2.71) .63
Concomitant CABG 2.64 (0.98–7.09) .05
Hypertension 0.82 (0.33–2.03) .67
Creatinine>150 mmol/L 2.16 (0.74–6.29) .15
Male sex 1.01 (0.42–2.37) .99
Diabetes mellitus 1.41 (0.27–7.12) .67
Hypercholesterolemia 1.38 (0.42–4.79) .60
Nonelective operation 1.49 (0.36–6.10) .56
Valve size (continuous variable) 0.89 (0.67–1.16) .37
LV impairment 1.21 (0.36–4.05) .75
Endocarditis 1.28 (0.24–5.9) .75
Redo operation 0.64 (0.25–1.68) .36
Preoperative NYHA III/IV 0.97 (0.44–2.13) .95
Aortic regurgitation 0.85 (0.34–2.53) .70
Mixed aortic valve disease 0.84 (0.41–2.91) .78
Aortic stenosis 1.58 (0.20–8.30) .92
Year of operation (first 5 y) 0.42 (0.15–1.15) .24
OR, Odds ratio; CI, confidence interval; CABG, coronary artery bypass grafting; LV,
left ventricular; NYHA, New York Heart Association.
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Covariates Model
In the subcoronary group patients the median propensity
score (0 ¼ RR and 1 ¼ subcoronary) was 0.71 (IQR,
0.42); in patients in the RR group the median score was
0.37 (IQR, 0.48). The c-statistic was 0.81 (area under the
curve), indicating satisfactory discrimination. Variables
and clinically important interactions included in the propen-
sity score model are listed in Table 3. We compared the bal-
ance of all baseline covariates in Table 1 between treatment
groups before and after propensity score matching by using
the absolute standardized difference (Figure 2), which di-
rectly quantifies the bias in the means (or proportions) of co-
variates across the groups, although in terms of modeling, as
we mentioned earlier, we used the propensity score in the
Cox regression model only as a covariate for adjustment be-
cause of sample size considerations. Variables included in
the propensity score model are listed in Table 3. The mortal-
ity across 5 cohort quintiles of propensity is shown in Table
4. The independent predictors of 30-day mortality and late
mortality are presented in Tables 5 and 6, respectively.
Valve-related Events
Actuarial freedom from valve-related events was deter-
mined by using the Kaplan–Meier product-limit method.
Freedom from structural valve deterioration at 1 and 5 years
was 98%  2% and 93%  5% for the RR group and
FIGURE 1. Actuarial survival. SCT, Subcoronary implantation; ROOT,
root replacement.
The Journal of Thoracic and C100% and 93%  3% for the subcoronary group, respec-
tively (P ¼ .35, Figure 3). Freedom from endocarditis for
the RR group at 1 and 5 years was 100% and 100% com-
pared with 97% 1.7% and 97% 1.7% for the subcoro-
nary group, respectively (P ¼ .18, Figure 4). Actuarial
freedom from reoperation for the RR group was 98%
 2% and 95%  3.2% at 1 and 5 years, respectively.
For patients in the subcoronary group, the 1- and 5-year
freedom from reoperation was 100% and 88%  5%, re-
spectively (Figure 5). This was not a significant difference
when the curves were compared by using the log-rank test
(P ¼ .66). Nine patients required reoperation: 6 in the
subcoronary group and 3 in the RR group. In 8 patients
the predominant valve lesion was aortic regurgitation
FIGURE 2. Balance in covariates before and after propensity matching.
SDAM, Standardized difference after matching; SDBM, standardized differ-
ence before matching.
TABLE 4. Mortality for patients undergoing the root replacement and





First quintile Patients in quintile 35 5
Deaths (n [%] of total) 7 (8.3) 0 (0)
Second quintile Patients in quintile 21 19
Deaths (n [%] of total) 4 (4.8) 4 (3.1)
Third quintile Patients in quintile 16 34
Deaths (n [%] of total) 1 (1.2) 2 (1.5)
Fourth quintile Patients in quintile 7 35
Deaths (n [%] of total) 1 (2.5) 3 (2.3)
Fifth quintile Patients in quintile 5 37
Deaths (n [%] of total) 2 (2.4) 1 (1.05)
RR, Root replacement; SC, subcoronary technique.
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tients, leaflet prolapse. Excessive calcification of the previ-
ous homograft at explantation was noted in only 1 patient
who underwent subcoronary implantation. One patient,
who underwent RR as an emergency procedure for endocar-
ditis, required reoperation on the day of the operation to re-
pair the homograft after excessive postoperative bleeding
from the aortic suture line. This patient died 18 days later
from multiorgan failure.
DISCUSSION
The aortic homograft has established itself as a reliable
valve substitute. Its hemodynamic characteristics are excel-
lent whether implanted in the subcoronary position or used
for total RR.20,21 The homograft’s resistance to infection is
a major reason why many surgeons choose to use the pros-
thesis for AVR in the setting of active endocarditis.5 The
avoidance of formal anticoagulation and a low incidence
of thromboembolism are additional advantages of its use.5
These benefits must be balanced against the prospect of
eventual valve failure caused by structural degeneration
and logistic issues associated with availability, preservation,
and storage. Excluding the use of the homograft as an inclu-
sion cylinder, subcoronary implantation and free-standing
RR are the 2 available techniques for valve insertion. Several
studies have compared these 2 implant methods with respect
to survival, freedom from structural valve disease, and reop-
eration.5-14 The overwhelming obstacle in comparing these
2 methods has been that the use of an individual technique
is often biased by other operation-related factors. In our se-
ries RR was associated with a high early mortality of 14%
compared with 2.2% for the subcoronary technique. This
figure is more easily understood when it is taken into account
that 36% of patients who underwent RR were undergoing
a redo AVR, with a further 18% being treated for active
TABLE 5. Logistic regression analysis (adjusted for covariatesmodel):
Independent predictors of 30-day mortality
Predictor OR (95% CI) P value
Reoperation 7.9 (1.8–34.8) .006
Subcoronary technique 0.15 (0.03–0.88) .04
Degenerative cause 4.9 (0.73–34.0) .10
Endocarditis 3.2 (0.62–16.7) .17
Left ventricular impairment 2.1 (0.44–9.7) .36
Aortic stenosis 0.40 (0.05–3.1) .38
Preoperative sinus rhythm 2.1 (0.44–9.7) .42
Aortic regurgitation 1.16 (0.18–7.2) .87
OR, Odds ratio; CI, confidence interval.
TABLE 6. Cox regression analysis (adjusted for covariates model):
Independent predictors of late mortality
Predictor HR (95% CI) P value
Reoperation 3.6 (1.1–12.4) .04
Left ventricular impairment 3.9 (0.96–15.5) .06
Preoperative sinus rhythm 1.7 (0.44–6.6) .44
Endocarditis 1.4 (0.14–14.4) .75
Aortic stenosis 0.77 (0.14–4.1) .76
Aortic regurgitation 0.75 (0.12–4.6) .75
Subcoronary technique 1.0 (0.24–4.3) .97
HR, Hazard ratio; CI, confidence interval.
FIGURE 3. Freedom from structural valve deterioration (SVD). SCT, Sub-
coronary implantation; ROOT, root replacement.
FIGURE 4. Freedom from endocarditis. SCT, Subcoronary implantation;
ROOT, root replacement.
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the RR technique was only 4.4% (2/45). This finding lends
further perspective toward understanding the dramatically
different patient risk profiles associated with the 2 tech-
niques of homograft insertion. We used propensity analysis
to adjust for such factors and correct for bias associated with
allocation to a particular implantation method. The propen-
sity score has been proposed as a better alternative in studies
with rare events and multiple baseline characteristics (con-
founders).22 A study by Cepeda and colleagues23 compared
both techniques. Propensity score analysis performed better
than logistic regression analysis in controlling for con-
founders when there were 7 or fewer events per baseline
characteristic.
Use of the RR technique was an independent predictor of
30-day mortality but not for overall mortality. In fact, all
deaths in the RR group occurred within the first postopera-
tive year. Beyond this time point, there were no further
deaths among patients in this group over the duration of
follow-up. It follows that the greatest risk to patients under-
going homograft RR is in the perioperative and early
postoperative periods. Inevitably, total RR is a more radical
surgical procedure than subcoronary implantation of an allo-
graft. Reimplantation of the coronary ostia, if complicated
by technical error, can lead to myocardial ischemia and peri-
operative myocardial infarction. Furthermore, there might
be an increased tendency for postoperative bleeding because
of several external suture lines. These factors can certainly
account for some increase in perioperative risk over that
seen with subcoronary valve insertion. Three of the early
deaths in patients undergoing RR were associated with peri-
operative bleeding, resulting in postoperative hemorrhage or
FIGURE 5. Freedom from reoperation. SCT, Subcoronary implantation;
ROOT, root replacement.
The Journal of Thoracic and Ccardiac tamponade with accompanying hemodynamic com-
promise. Previous studies have demonstrated an overall sur-
vival advantage for the RR technique over subcoronary
implantation.5 We were unable to demonstrate a survival
benefit for RR over subcoronary implantation in our series.
Older studies with long follow-up periods frequently span 2
or 3 decades.5,6 Over such a protracted length of time, signif-
icant changes are bound to occur with respect to all aspects
of cardiac surgery, ranging from anesthesia, myocardial pro-
tection, and postoperative management to surgical tech-
nique, perioperative evaluation of procedure quality, and
increasing understanding of disease pathophysiology. In
the context of homograft AVR, important changes that
have occurred over the past 30 years have included a shift
from initial techniques of preservation of allografts by using
antibiotic solution to the use of fresh viable allografts and the
now preferred and more practical method of cryopreserva-
tion. Similarly, there has been a trend over time toward re-
placing subcoronary implantation with RR. When series of
procedures are compared over such widely separated time
periods, it is inevitable that changing practice over different
eras can prejudice the outcome of any comparison. Although
logistic regression and statistical modeling can adjust for
many factors, it cannot completely account for all variables
related to different time periods. Our study was conducted
over a decade, and during this period, protocols for preserva-
tion, surgical intervention, and anesthesia remained rela-
tively unchanged.
A number of authors have reported an increased risk of re-
operation associated with the subcoronary technique.5,24
This has been validated by a recent meta-analysis of several
studies comparing the subcoronary and RR techniques for
homograft insertion, which also identified an increased
risk of reoperation after subcoronary implantation.25 There
are several reasons for reoperation in patients having under-
gone homograft AVR. Because the incidence of endocarditis
is exceedingly low, as demonstrated in our series and other
reports, this is a rare cause for reoperation. The most com-
mon cause is structural valve deterioration. Homografts,
like all bioprostheses, degenerate over time. Important fac-
tors associated with accelerated degeneration have been
identified as younger recipient age and older age of the ho-
mograft donor.5 In our study there was no difference in 1-
or 5-year actuarial freedom from structural valve disease
or reoperation between patients in the subcoronary and RR
groups. The major clinical manifestations of structural valve
disease are the development of significant aortic insuffi-
ciency or aortic stenosis noted by an increasing transvalvular
gradient measured by means of echocardiographic analysis.
These features can be detected as part of routine investiga-
tion or present as a deterioration in the patient’s clinical con-
dition. In our series 9 patients required reoperation over the
course of follow-up. Six patients previously had a subcoro-
nary allograft, and the remaining 3 underwent RR. In 8 of
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was secondary to leaflet tearing and prolapse, which is indic-
ative of fatigue failure of the valve associated with repetitive
strain and insult. Early reoperation is reported to be much
more frequent after subcoronary insertion.24 Technical er-
rors relating to homograft sizing and failure to achieve ap-
propriate geometry of the allograft within the aortic root
are 2 major reasons for early valve failure. Willems and as-
sociates24 documented that the learning curve associated
with subcoronary implantation is a major reason for early re-
operation. Such a learning curve inevitably includes the fac-
tors mentioned above, which relate to technical details of
subcoronary allograft insertion. The number of patients
who required reoperation in ours series was low. The abso-
lute incidence was only 4.1% (9/215) over the follow-up pe-
riod. Five-year actuarial freedom from reoperation was 95%
for RR and 88% for subcoronary implantation.
Both the subcoronary and RR techniques allow for com-
parable midterm survival and freedom from structural valve
disease and reoperation. The technique used should in all
cases be tailored to the individual patient. In our series sub-
coronary insertion was predominantly used for uncompli-
cated, degenerative, calcific aortic valve disease. RR is
likely to remain the preferred method in the presence of aor-
tic root disease, endocarditis, and aortic valve reoperations.
Furthermore, as a consequence of being a more radical pro-
cedure, RR might pose greater perioperative risk to the pa-
tient, independent of other operation-related factors. After
propensity adjustment, RR was an independent predictor
of 30-day mortality. Many of these early deaths were caused
by low cardiac output syndrome in the early perioperative
period. It is conceivable that specific technical details related
to RR might be responsible for this observation. The need
for reimplantation of the coronary ostia during RR might
compromise myocardial perfusion if technical errors were
to occur during this component of the procedure. The asso-
ciation between RR and low cardiac output syndrome re-
quires further investigation. Despite a well-recognized risk
of valve failure over the longer term, allograft AVR is asso-
ciated with specific advantages over other prostheses related
to their more physiologic performance and low incidence of
valve-related morbidity. Furthermore, with improvement in
surgical technique, myocardial management, and periopera-
tive patient care, aortic valve reoperation is becoming in-
creasingly safe.26,27 Consequently, patients can enjoy the
lifestyle benefits that accompany the use of allografts and bi-
oprosthetic AVR in general, secure in the knowledge that the
risk associated with redo AVR can be considered far from
prohibitive. There remains concern that reoperative proce-
dures in patients with a previous homograft can be a difficult
undertaking, particularly when dense calcification of the ho-
mograft aortic wall complicates RR. In a previous report we
have demonstrated that the use of a homograft at primary op-
eration does not increase the risk of redo AVR.28
Study Limitations
Our study has several limitations, primarily relating to our
methodology and sample size. First, it is nearly impossible
to account for all the differences between patients and the se-
lection process involved in determining the method of ho-
mograft implantation. A principal difficulty is ascertaining
whether patients in both groups were suitable for both pro-
cedures. This can only be guaranteed in the setting of a ran-
domized controlled trial. Although propensity analyses are
a powerful statistical technique, they are inherently limited
by the number and accuracy of the variables evaluated. Fur-
thermore, the low perioperative mortality at our institution
poses an important limitation with regard to applicability
of the data. Finally, because our median follow-up was
less than 10 years, the very long-term life expectancy impli-
cations for patients in our series remain undetermined. A
number of existing studies include longer follow-up periods;
however, they did not use propensity analysis to treat alloca-
tion bias.16-19 The propensity technique used in this study
was responsible for the residual imbalance in covariates after
propensity score matching, and this needs to be considered
as a limitation of our study. It was not possible to apply other
techniques to compensate for this because of sample size
constraints. Finally, our current length of follow-up does
not allow us to comment on differences in clinical outcomes
10 years after AVR by using either technique. We aim to an-
alyze such outcomes in future reports as we gain further fol-
low-up data from our patient cohort.
CONCLUSIONS
Implantation technique was not associated with any im-
portant differences in clinical performance over the longer
term in our study. RR was, however, associated with an in-
crease in 30-day mortality. Both methods result in excellent
outcomes; however, there remains an attendant risk of struc-
tural valve failure that might necessitate reoperation. For al-
most 5 decades, the aortic homograft has established itself as
a reliable valve substitute. The allograft proves itself to be
especially valuable in the difficult setting of active endocar-
ditis and redo aortic valve procedures. Both the subcoronary
and RR implantation techniques for AVR can be used by the
surgeon in the knowledge that they are associated with ex-
cellent clinical results. The apparent association between
RR and increased perioperative mortality warrants further
investigation.
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